2017
DOI: 10.1016/j.radonc.2017.07.031
|View full text |Cite
|
Sign up to set email alerts
|

Caution is required in the implementation of 90-day mortality indicators for radiotherapy in a curative setting: A retrospective population-based analysis of over 16,000 episodes

Abstract: Background90-day mortality (90 DM) has been proposed as a clinical indicator in radiotherapy delivered in a curative setting. No large scale assessment has been made. Its value in allowing robust comparisons between centres and facilitating service improvement is unknown.MethodsAll radiotherapy treatments delivered in a curative setting over seven years were extracted from the local electronic health record and linked to cancer registry data. 90 DM rates were assessed and factors associated with this outcome w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 17 publications
1
5
0
Order By: Relevance
“…Spencer et al also recently reported on 90‐day mortality after curative RT in Leeds, United Kingdom, for all tumor sites . Interestingly, their 90‐day mortality rate for the 1156 patients with head and neck cancer who were included was 3.7%, with 83% of deaths attributed to treatment or the underlying cancer, nearly identical to the results in our study …”
Section: Discussionsupporting
confidence: 90%
“…Spencer et al also recently reported on 90‐day mortality after curative RT in Leeds, United Kingdom, for all tumor sites . Interestingly, their 90‐day mortality rate for the 1156 patients with head and neck cancer who were included was 3.7%, with 83% of deaths attributed to treatment or the underlying cancer, nearly identical to the results in our study …”
Section: Discussionsupporting
confidence: 90%
“…The enrolled patients were stage III, IVA, or IVB patients who received standard concurrent chemoradiation (CCRT) at a single institution to minimize bias effects from a heterogeneous population and different treatment protocols. The reported 60 and 90-day short-term mortality for LAHNC patients after completion of CCRT ranged from 4.7% to 7.2% [8][9][10][11], but the one year mortality can escalate up to 25% [12][13][14]. Understanding the relevant nutritional assessment parameters for prediction of one year mortality in LAHNC patients will allow clinicians to identify malnutrition early and offer prompt action that may reduce mortality.…”
Section: Introductionmentioning
confidence: 99%
“…This cut-off was chosen, as it was reported in the two quoted ASTRO abstracts [3] , [4] , and also because it is commonly used in the palliative RT literature when assessing therapy close to end-of-life [6] , [7] . While it is an open question of whether 30-, 90- or even 180-day mortality after RCT should be regarded as quality measure, the contrast between a high potential for cure after a weeks-long therapy regimen versus death during or shortly after therapy seems most pronounced [2] , [8] . Curative therapy was defined as curative-intent per the treating radiation oncologist, with a prescribed dosage of an equivalent in 2 Gy single dose (EQD2) ≥ 50 Gy for RTs alone, EQD2 ≥ 40 Gy for RCTs and even lower dose cut-offs for lymphoma patients.…”
Section: Methodsmentioning
confidence: 99%
“…Mortality during or shortly after treatment, often termed peri-radiotherapeutic (peri-RT) mortality , in patients undergoing curative-intent radiotherapy (RT) or radiochemotherapy (RCT) have not been studied systematically. Only a few site-specific and one more broadly conceptualized report are published in the pertinent literature to date [1] , [2] .…”
Section: Introductionmentioning
confidence: 99%